MktsMarkets

Harmony Biosciences Holdings, Inc.
NASDAQ: HRMYKey statistics
HRMY News
Stories mentioning HRMY from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 215,387 | 243,776 | 239,455 | 200,489 | 184,733 | 201,267 | 186,038 | 172,814 |
| Cost of Goods Sold | 44,512 | 68,545 | 59,650 | 38,153 | 31,994 | 54,409 | 42,778 | 32,144 |
| Gross Profit | 170,875 | 175,231 | 179,805 | 162,336 | 152,739 | 146,858 | 143,260 | 140,670 |
| Operating Expenses | ||||||||
| Research & Development | 69,383 | 49,933 | 54,962 | 50,159 | 34,540 | 34,666 | 25,387 | 63,583 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 133,584 | 136,674 | 114,318 | 114,156 | 96,494 | 91,131 | 81,550 | 119,314 |
| Operating Income (Loss) | 37,291 | 38,557 | 65,487 | 48,180 | 56,245 | 55,727 | 61,710 | 21,356 |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (127.00) | (105.00) | (106.00) | (193.00) | (276.00) | 160.00 | (124.00) | 37.00 |
| Pretax Income | 39,687 | 40,760 | 67,490 | 49,637 | 57,177 | 56,155 | 62,170 | 21,694 |
| Tax Provision | 7,199 | 18,274 | 16,625 | 9,861 | 11,617 | 6,680 | 16,077 | 10,103 |
| Net Income (Loss) | 32,488 | 22,486 | 50,865 | 39,776 | 45,560 | 49,475 | 46,093 | 11,591 |
| Earnings Per Share (Basic) | 0.56 | 0.39 | 0.88 | 0.69 | 0.79 | 0.87 | 0.81 | 0.20 |
| Earnings Per Share (Diluted) | 0.55 | 0.38 | 0.87 | 0.68 | 0.78 | 0.85 | 0.79 | 0.20 |
| Weighted Average Shares Outstanding (Basic) | 57,819 | 57,492 | 57,551 | 57,470 | 57,310 | 56,885 | 56,870 | 56,802 |
| Weighted Average Shares Outstanding (Diluted) | 58,776 | 58,545 | 58,718 | 58,427 | 58,525 | 57,870 | 58,104 | 57,542 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HRMY
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is a stock listed on the Nasdaq Stock Market under the ticker symbol HRMY. It last traded at $33.11 (Nov 6, 2026, 4:00 PM ET), up 2.0% on the day. That gives Harmony Biosciences a market capitalisation of $1.9B and a price-to-earnings ratio of 10.6.
Over the past 52 weeks HRMY has traded between $25.90 and $43.49.
Revenue for the quarter ended Mar 31, 2026 was $215.4M; net income $32.5M. Revenue was up 16.6% from $184.7M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $215.4M | $32.5M | 15.1% |
| Dec 31, 2025 | $243.8M | $22.5M | 9.2% |
| Sep 30, 2025 | $239.5M | $50.9M | 21.2% |
| Jun 30, 2025 | $200.5M | $39.8M | 19.8% |
From Harmony Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…